NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Exploring Three High Growth Tech Stocks in the United States

In the last week, the United States market has been flat, yet it has shown a robust 21% increase over the past year, with earnings expected to grow by 14% annually in the coming years. In this context of overall market growth and stability, identifying high growth tech stocks involves looking for companies with strong innovation potential and solid financial health that can capitalize on these favorable conditions.
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (NYSE:GMED) Reports Strong Sales Growth But Sees US$20 Million Dip In Annual Net Income

Globus Medical (NYSE:GMED) recently reported mixed financial results, with a significant rise in sales to USD 2,519 million but a drop in net income to USD 103 million for the full year ending December 2024. The company's share price exhibited a minor shift of 0.01% in the past week, occurring amidst broader market fluctuations that saw major indexes like the Dow Jones and Nasdaq experience declines due to factors including the UnitedHealth DOJ probe and tech stock performance. While Globus...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Coca-Cola Consolidated (NasdaqGS:COKE) Reports Strong Earnings Growth With US$179 Million Q4 Net Income

Coca-Cola Consolidated (NasdaqGS:COKE) has reported a notable 14.50% price increase over the past quarter. Several factors likely influenced this uptick. The company's robust financial performance, marked by a rise in fourth-quarter sales to $1,747 million and a substantial increase in net income, showcased its strong market position. The completion of a share buyback program, with 42,895 shares repurchased for $51.64 million, likely bolstered investor confidence. Additionally, a declared...
NasdaqGS:HOLX
NasdaqGS:HOLXMedical Equipment

Hologic (NasdaqGS:HOLX) Expands Global Reach With CE-Marked Affirm Contrast Biopsy Software

Hologic (NasdaqGS:HOLX) recently announced the CE-marking of its Affirm Contrast Biopsy Software, enhancing its breast imaging portfolio with advanced diagnostic capabilities. Concurrently, the company's Aptima SARS-CoV-2 assay gained 510(k) FDA clearance, solidifying its commitment to respiratory diagnostics. Over the last week, Hologic's share price saw a modest increase of 1.1%. This price movement occurred amidst a backdrop of downward pressures in major markets, with the Dow Jones, S&P...
NYSE:DVA
NYSE:DVAHealthcare

DaVita (NYSE:DVA) Reports Financial Improvements For 2024 But Stock Dips 12%

DaVita Inc. (NYSE:DVA) has reported substantial financial improvements for the full year 2024, including increased revenues and net income, along with continued share repurchases. Despite these positive earnings indicators, DaVita's stock price decreased by 12% over the last quarter. During this period, the company's extensive share buyback activity, which included the repurchase of over 3.1 million shares, was intended to bolster shareholder value. However, it seems that broader market...
NYSE:EHC
NYSE:EHCHealthcare

Encompass Health (NYSE:EHC) Declares Quarterly Dividend of US$0.17 Per Share

Encompass Health (NYSE:EHC) has seen a notable increase of 4.3% in its share price over the past month. This positive movement aligns with some of the company's recent announcements and broader market trends. Key developments include the affirmation of a quarterly dividend of $0.17 per share, and the positive earnings report released in early February, which highlighted increased sales and net income compared to the previous year. Furthermore, the company's plans for significant business...
NasdaqGM:LWAY
NasdaqGM:LWAYFood

Undiscovered Gems in the United States for February 2025

In the last week, the United States market has been flat, yet it has experienced a notable 21% rise over the past year with earnings projected to grow by 14% annually. In this dynamic environment, identifying stocks that are undervalued or overlooked can provide unique opportunities for investors seeking to capitalize on potential growth.